UB Paderborn / Katalog / Suche / in CDI

Amiselimod, a sphingosine 1-phosphate receptor-1 modulator, for systemic lupus erythematosus: A multicenter, open-label exploratory study

Lupus, 2020-12, Vol.29 (14), p.1902-1913

2020

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of pharmacokinetic and pharmacodynamic interactions of canagliflozin and teneligliptin in Japanese healthy male volunteers

Expert opinion on drug metabolism & toxicology, 2015-01, Vol.11 (1), p.7-14

2015

Link zum Volltext

Verfügbarkeit prüfen

Chronic kidney disease in postmenopausal women

Hypertension research, 2012-02, Vol.35 (2), p.142-147

2012

Link zum Volltext

Verfügbarkeit prüfen

Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan

Therapeutic apheresis and dialysis, 2021-10, Vol.25 (5), p.642-653

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of canagliflozin alone or as add‐on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52‐week open‐label study

Journal of diabetes investigation, 2015-03, Vol.6 (2), p.210-218

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of valbenazine in Japanese patients with tardive dyskinesia: A multicenter, randomized, double‐blind, placebo‐controlled study (J‐KINECT)

Psychiatry and clinical neurosciences, 2022-11, Vol.76 (11), p.560-569

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase 3, open‐label, single‐arm study of vadadustat for anemia in chronic kidney disease for Japanese patients on hemodialysis not receiving erythropoiesis‐stimulating agents

Therapeutic apheresis and dialysis, 2022-02, Vol.26 (1), p.45-54

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction: Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan

PloS one, 2022-04, Vol.17 (4), p.e0261932-e0261932

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Pharmacokinetics, Safety, and Drug‐Drug Interactions of an Oral Suspension of Edaravone in Healthy Adults

Clinical pharmacology in drug development, 2021-10, Vol.10 (10), p.1174-1187

2021

Link zum Volltext

Verfügbarkeit prüfen

Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan

PloS one, 2018-08, Vol.13 (8), p.e0201956

2018

Link zum Volltext

Verfügbarkeit prüfen

Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan

BMC pediatrics, 2019-10, Vol.19 (1), p.351-351, Article 351

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of dose escalation of infliximab therapy in Japanese patients with psoriasis: Results of the SPREAD study

Journal of dermatology, 2017-05, Vol.44 (5), p.552-559

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD

Journal of the American Society of Nephrology, 2021-07, Vol.32 (7), p.1779-1790

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study

Nephrology, dialysis, transplantation, 2021-09, Vol.36 (9), p.1731-1741

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus

Journal of diabetes investigation, 2013-11, Vol.4 (6), p.576-584

2013

Link zum Volltext

Verfügbarkeit prüfen

In Vitro and Clinical Pharmacokinetic Studies of the Effects of Iron-containing Agents on Vadadustat, an Oral Hypoxia-inducible Factor–Prolyl Hydroxylase Inhibitor

Clinical therapeutics, 2021-08, Vol.43 (8), p.1408-1418.e5

2021

Link zum Volltext

Verfügbarkeit prüfen

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study

Medicine (Baltimore), 2016-06, Vol.95 (24), p.e3863

2016

Link zum Volltext

Verfügbarkeit prüfen

An Open-label, Single-dose Study to Evaluate the Pharmacokinetic Variables of Edaravone in Subjects with Mild, Moderate, or No Renal Impairment

Clinical therapeutics, 2020-09, Vol.42 (9), p.1699-1714

2020

Link zum Volltext

Verfügbarkeit prüfen

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2014-12, Vol.15 (7-8), p.610-617

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Lancet neurology, 2017-07, Vol.16 (7), p.505-512

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension

Diabetes, obesity & metabolism, 2014-05, Vol.16 (5), p.418-425

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study

Expert opinion on pharmacotherapy, 2014-08, Vol.15 (11), p.1501-1515

2014

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of pharmacokinetic and pharmacodynamic interactions of canagliflozin and teneligliptin in Japanese healthy male

Expert opinion on drug metabolism & toxicology, 2015-01, Vol.11 (1), p.7-14

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of canagliflozin as add‐on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24‐week, randomized, double‐blind, placebo‐controlled trial

Diabetes, obesity & metabolism, 2017-06, Vol.19 (6), p.874-882

2017

Link zum Volltext

Verfügbarkeit prüfen

Open-label, Single-dose Studies of the Pharmacokinetics of Edaravone in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects with Normal Hepatic Functioning

Clinical therapeutics, 2020-08, Vol.42 (8), p.1467-1482.e4

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Amiselimod, a sphingosine 1-phosphate receptor-1 modulator, for systemic lupus erythematosus: A multicenter, open-label exploratory study

Evaluation of pharmacokinetic and pharmacodynamic interactions of canagliflozin and teneligliptin in Japanese healthy male volunteers

Chronic kidney disease in postmenopausal women

Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan

Efficacy and safety of canagliflozin alone or as add‐on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52‐week open‐label study

Efficacy and safety of valbenazine in Japanese patients with tardive dyskinesia: A multicenter, randomized, double‐blind, placebo‐controlled study (J‐KINECT)

A phase 3, open‐label, single‐arm study of vadadustat for anemia in chronic kidney disease for Japanese patients on hemodialysis not receiving erythropoiesis‐stimulating agents

Correction: Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan

Evaluation of Pharmacokinetics, Safety, and Drug‐Drug Interactions of an Oral Suspension of Edaravone in Healthy Adults

Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan

Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan

Efficacy and safety of dose escalation of infliximab therapy in Japanese patients with psoriasis: Results of the SPREAD study

Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD

Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study

Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus

In Vitro and Clinical Pharmacokinetic Studies of the Effects of Iron-containing Agents on Vadadustat, an Oral Hypoxia-inducible Factor–Prolyl Hydroxylase Inhibitor

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study

An Open-label, Single-dose Study to Evaluate the Pharmacokinetic Variables of Edaravone in Subjects with Mild, Moderate, or No Renal Impairment

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension

Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study

Evaluation of pharmacokinetic and pharmacodynamic interactions of canagliflozin and teneligliptin in Japanese healthy male

Efficacy and safety of canagliflozin as add‐on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24‐week, randomized, double‐blind, placebo‐controlled trial

Open-label, Single-dose Studies of the Pharmacokinetics of Edaravone in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects with Normal Hepatic Functioning

Suchergebnisse filtern